Pancreatic Cancer Clinical Trials

Trials for someone you care about with pancreatic cancer.

Cancer

Recruiting Drug Device Behavioral Older adults Healthy volunteers

15 trials

Comparing Everolimus with Zanzalintinib for pancreatic neuroendocrine tumor (pnet)

Explore this study →

Sites in London, Ottawa and 1 more city

Official title: Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Pancreatic Neuroendocrine Tumor (pNET) · Exelixis

Comparing Gemcitabine with Dose-escalated Radiation Therapy for locally advanced unresectable pancreatic ductal

Explore this study →

One site, in Edmonton

RecruitingPHASE3

Official title: Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma · NRG Oncology

Testing enoxaparin/tinzaparin/dalteparin for pancreas cancer

Explore this study →

One site, in Toronto

RecruitingPHASE4

Official title: Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery

Pancreas Cancer · Helsinki University Central Hospital

Get them matched to the best-fit trials

Answer a few questions and we'll find the closest matches for pancreatic cancer.

Testing Biospecimen Collection with Computed Tomography for metastatic pancreatic neuroendocrine tumor

Explore this study →

One site, in Toronto

RecruitingPHASE1

Official title: Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Metastatic Pancreatic Neuroendocrine Tumor · National Cancer Institute (NCI)

Comparing Cobimetinib with Ponatinib for pancreatic ductal carcinoma

Explore this study →

One site, in Toronto

RecruitingPHASE2

Official title: Using Tumor Models to Determine Treatments

Pancreatic Ductal Carcinoma · University Health Network, Toronto

Comparing 3 approaches for pancreatic ductal adenocarcinoma (PDAC)

Explore this study →

2 sites in Toronto

RecruitingPHASE2

Official title: A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma (PDAC) · Verastem, Inc.

Comparing 3 approaches for pancreatic cancer

Explore this study →

One site, in Edmonton

RecruitingPHASE2

Official title: Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Pancreatic Cancer · AHS Cancer Control Alberta

Testing [68Ga]Ga-NNS309 with [177Lu]Lu-NNS309 for pancreatic ductal adenocarcinoma

Explore this study →

Sites in Montreal and Toronto

RecruitingPHASE1

Official title: Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Pancreatic Ductal Adenocarcinoma · Novartis Pharmaceuticals

Comparing 3 approaches for pancreatic ductal adenocarcinoma

Explore this study →

Sites in Ottawa and Toronto

RecruitingPHASE1

Official title: MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Pancreatic Ductal Adenocarcinoma · Eli Lilly and Company

Testing 68Ga-NNS309 with 177Lu-DFC413 for pancreatic ductal adenocarcinoma

Explore this study →

One site, in Montreal

RecruitingPHASE1

Official title: Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Pancreatic Ductal Adenocarcinoma · Novartis Pharmaceuticals

Testing WEF-001 for advanced or metastatic KRAS-mutant tumor in pancreatic

Explore this study →

One site, in Toronto

RecruitingPHASE1

Official title: Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma · Auricula Biosciences Inc.

Testing mFOLFIRINOX with Gemcitabine / Nab-paclitaxel for pancreatic adenocarcinoma

Explore this study →

One site, in Hamilton

RecruitingPHASE2

Official title: Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery

Pancreatic Adenocarcinoma · Hamilton Health Sciences Corporation

Testing Durvalumab with Oleclumab for pancreatic ductal adenocarcinoma

Explore this study →

One site, in Toronto

RecruitingPHASE2

Official title: Durvalumab and Oleclumab in Resectable PDAC

Pancreatic Ductal Adenocarcinoma · University Health Network, Toronto

Comparing Autogene cevumeran with mFOLFIRINOX for pancreatic ductal adenocarcinoma

Explore this study →

Sites in Montreal and Toronto

RecruitingPHASE2

Official title: A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Adenocarcinoma, Pancreatic Ductal · Genentech, Inc.

Testing Fecal Microbiota Transplantation with PEG3350 for unresectable or metastatic advanced pancreatic ductal

Explore this study →

One site, in London

RecruitingPHASE1

Official title: CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)

Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma · John Lenehan

Looking for the closest fit?

Get matched →

Get notified when a matching trial opens

We'll watch for Pancreatic Cancer trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.